GSK - VERDICT CONSISTENT WITH SCIENTIFIC CONSENSUS THAT THERE IS NO CONSISTENT OR RELIABLE EVIDENCE THAT RANITIDINE INCREASES THE RISK OF ANY CANCER
Gsk - Verdict Consistent With Scientific Consensus That There Is…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,608 GBX | +0.59% |
|
+0.53% | +10.92% |
06-24 | Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer | CI |
06-24 | European Equities Close Higher on Monday; EU Probes Apple for Breach of Digital Competition Law | MT |
GSK - VERDICT CONSISTENT WITH SCIENTIFIC CONSENSUS THAT THERE IS NO CONSISTENT OR RELIABLE EVIDENCE THAT RANITIDINE INCREASES THE RISK OF ANY CANCER
1st Jan change | Capi. | |
---|---|---|
+10.92% | 83.25B | |
+52.70% | 801B | |
+41.58% | 631B | |
-4.86% | 359B | |
+21.96% | 337B | |
+11.47% | 305B | |
+17.72% | 245B | |
+4.46% | 231B | |
+13.13% | 219B | |
+10.46% | 171B |